BridgeBio Pharma LLC
SEC insider (Form 3/4/5 filer). CIK 0002076615. 10% Owner at BridgeBio Oncology Therapeutics, Inc. (BBOT). 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 10, 2025. Located in PALO ALTO, CA.
Companies BridgeBio Pharma LLC has filed insider reports for
- BridgeBio Oncology Therapeutics, Inc. (BBOT): 10% Owner
BridgeBio Pharma LLC
CIK: 0002076615
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BBOT
BridgeBio Oncology Therapeutics, Inc.
10% Owner